SCHEMBL18878274

SCHEMBL18878274

CC1(C)c2ccccc2-c2c(-c3ccc(-c4nc(-c5ccccc5)nc(-c5ccc(-c6ccccc6)cc5)n4)cc3)cccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.41
ADORA3 P0DMS8 2/20 0.39
ADORA2A P29274 2/20 0.39
ADORA2B P29275 2/20 0.39
ADORA1 P30542 2/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
PDK2 Q15119 11/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 3/20 0.36
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
KMT2A Q03164 2/20 0.36
GPR55 Q9Y2T6 1/20 0.35
LMNA P02545 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17151617 1.00 L3MBTL1 (0.41) L3MBTL1ADORA3ADORA2AADORA2BADORA1
SCHEMBL17151705 1.00 L3MBTL1 (0.41) L3MBTL1ADORA3ADORA2AADORA2BADORA1
SCHEMBL31664377 0.98 L3MBTL1 (0.42) L3MBTL1ADORA3ADORA2AADORA2BADORA1
SCHEMBL22059017 0.98 L3MBTL1 (0.42) L3MBTL1ADORA3ADORA2AADORA2BADORA1
SCHEMBL23697564 0.94 L3MBTL1 (0.37) L3MBTL1ADORA3ADORA2AADORA2BADORA1
SCHEMBL17151621 0.94 L3MBTL1 (0.37) L3MBTL1ADORA3ADORA2AADORA2BADORA1
SCHEMBL26937585 0.94 L3MBTL1 (0.37) L3MBTL1ADORA3ADORA2AADORA2BADORA1
SCHEMBL23697106 0.94 L3MBTL1 (0.37) L3MBTL1ADORA3ADORA2AADORA2BADORA1
SCHEMBL18463575 0.94 L3MBTL1 (0.37) L3MBTL1ADORA3ADORA2AADORA2BADORA1
SCHEMBL18463350 0.94 L3MBTL1 (0.37) L3MBTL1ADORA3ADORA2AADORA2BADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021150048-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2021-07-29 WO disclosed
US-20210074925-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-03-11 US disclosed
US-20170148995-A1 ORGANIC LIGHT EMITTING DISPLAY DEVICE LG DISPLAY CO., LTD. (KR) 2017-05-25 US disclosed
US-20170148995-A1 ORGANIC LIGHT EMITTING DISPLAY DEVICE LG DISPLAY CO., LTD. (KR) 2017-05-25 US disclosed
US-20160346270-A1 BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 AUSPEX PHARMACEUTICALS, INC. 2016-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160346270-A1 BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 SLC18A2, SLC6A2, SLC18A1 L3MBTL1 4418/4885ADORA3 773/4885ADORA2A 398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.